We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
AtriCure Inc. said Sunday that it has received the European Union's CE Mark approval to market its cardiac device for the treatment of cardiac arrhythmias.
Endocare, Inc., an innovative medical device company focused on the development of minimally invasive technologies for tissue and tumor ablation, announced that it has received 510K clearance from the U.S. Food and Drug Administration to market its new Cryocare CN2 System, a potentially much faster and easier-to-operate cryoablation system for freezing cancerous tumors and tissue.
Neuroptix Corporation, a Massachusetts-based Alzheimer's diagnostics company, announced that recent tests of its Optiscan diagnostic platform on mice demonstrated that the optical scanning system was able to detect amyloid protein aggregates in the lens of the eye prior to toxic plaque build-up in the brain.
Jim Cornelius, who built a long career in executive positions at Eli Lilly and Co. and Guidant Corp., has been named interim chief executive of Bristol-Myers Squibb after the drug maker ousted CEO Peter R. Dolan over a soured patent agreement for its blockbuster drug Plavix.
Medtronic Inc. said Tuesday it will have a plan to correct problems with two of its drug-pump catheters this week after the U.S. Food and Drug Administration slapped its most serious recall designation on the devices.
Applied Medical Resources has filed a patent infringement countersuit in the Eastern District of Texas against Tyco Healthcare and its subsidiary U.S. Surgical in response to a patent suit filed by Tyco, Applied Medical announced Sept. 12.
HYPRES has been awarded a nine-month, $100,000 contract with the U.S. Department of Energy (DOE) to develop a low-noise superconducting quantum interference device (SQUID)-based amplifier chip for high-speed applications, the firm said Sept. 12.